All systems go for mobile health and true connectivity

7 March 2017
melissa-manice-dana-shears

In an expert view piece, Dana Shears (pictured above, right) eMDI business development director of H&T Presspart and Melissa Manice (left), chief executive and co-founder of Cohero Health, look at how advances in mobile health and connected devices are opening up unprecedented opportunities in the management of chronic diseases.

We are now seeing the potential of digital health being fulfilled when it comes to managing the burden of chronic disease in cost-constrained healthcare systems. For patients suffering from chronic conditions such as diabetes, heart disease, asthma and chronic obstructive pulmonary disease (COPD), technological advances in digital health are making day-to-day monitoring and tracking much easier.

The plethora of medical and fitness apps that are getting to market are impressive technology-wise. However, the really exciting potential lies in leveraging connected hardware and mobile technology to improve the management of chronic diseases – daily and around the clock – with the same high level of reliability and security that patients expect from their medication.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical